Cannara Biotech Inc

TSX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:59

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeTSX

Market Capitalization198.55 mln

Float47.39 mln

Earnings Date11/24/2026

EPS

0.11

Marginal

P / E

18.18

Moderately valued

Piotroski F-Score

7 / 9

Strong

Beneish M-Score

4.66

Highly suspicious

Relative Strength

17 / 100

Significantly lagging

Debt / Equity

0.29

Very low leverage

Business Description

Cannara Biotech Inc. is a Canadian company that grows, processes, and sells cannabis products indoors, marketing them under the TRIBAL nugz and ORCHID CBD brands. Founded in 2017 and based in Saint-Laurent, the company reaches customers through wholesalers and online retailers. Alongside its cannabis business, Cannara also holds and manages real estate assets.

Key Fundamentals

EPS0.11

P/E18.18

ROE9.73

RPS1.23

ROIC-3.73

ROA6.11

Interest Cover0.04

EBITDA, mln25.78

EV / EBITDA8.98

EV / EBIT12.16

Revenue, mln117

EV / Revenue1.97

Quote Details

Last 2.00

Change -0.03 (-1.48%)

Open 2.00

Volume 40,902

Turnover 81,804

Average Volume 31,116

Financial Ratios

Pre-Tax Profit Margin14

Leverage Ratio1.55

Current Ratio3.00

Price / Book1.73

Price / Tangible Book1.76

Price / Cash Flow10.76

Price / Free Cash Flow55.00

Debt / Equity0.29

Price / Sales1.81

Financial Strength

Altman Z-Score3.25

Piotroski F-Score 7 / 9

Beneish M-Score4.66

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-1.96%	20 / 100
1 Month	-9.5%	17 / 100
2 Months	5.82%	75 / 100
6 Months	12.36%	78 / 100